Table 1.
Clinicopathological features of 157 oesophageal SCC patients
| Characteristics | n (%) |
|---|---|
| Gender | |
| Male | 95 (60.5) |
| Female | 62 (39.5) |
| Age (years) | |
| ≤57 | 79 (50.3) |
| >57 | 78 (49.7) |
| Histological grade | |
| Well differentiated | 59 (37.6) |
| Moderately differentiated | 47 (29.9) |
| Poorly differentiated | 51 (32.5) |
| Tumour location | |
| Upper | 17 (10.8) |
| Middle | 109 (69.4) |
| Lower | 31 (19.7) |
| Tumour size (mm) | |
| <30 | 34 (21.7) |
| 30–60 | 109 (69.4) |
| >60 | 14 (8.9) |
| Clinical stage | |
| I | 3 (1.9) |
| II | 96 (61.1) |
| III | 11 (7.0) |
| IV | 37 (23.6) |
| Unknown | 10 (6.4) |
| T stage | |
| T1 | 5 (3.2) |
| T2 | 54 (34.4) |
| T3 | 70 (44.6) |
| T4 | 18 (11.4) |
| Tx | 10 (6.4) |
| Lymph node metastasis | |
| Negative | 90 (57.3) |
| Positive | 57 (36.3) |
| Unknown | 10 (6.4) |
| Distant metastasis | |
| No | 120 (76.4) |
| Yes | 37 (23.6) |
| CD117 expression | |
| Negative | 110 (70.1) |
| Weakly positive | 15 (9.6) |
| Moderately positive | 15 (9.6) |
| Strongly positive | 17 (10.8) |